Liliia Hala, Hanna Panfilova


The effectiveness of the system of pharmaceutical supply to the population depends on the proper interaction of the state and market mechanisms for regulating the interests of all subjects of the pharmaceutical market for the implementation of the social policy of the state regarding the availability of quality and effective medicines for the population. In the context of healthcare reform, the issues of assessing the main stages of the development of the pharmaceutical supply system of the population become especially relevant.

Aim. Determination of key, from organizational, economic and social points of view, stages of formation of the domestic system of pharmaceutical supply of the population, analysis of the main tendencies of its development in retrospect years.

Materials and methods. The materials of the research were selected by the regulatory acts, the data of the specialized literature, certain aspects of activity of subjects of the pharmaceutical market, etc. Methods such as historical, informational-analytical, analytical-comparative, systemic, logical, hypothetical-deductive and generalization were used.

Results. Based on the conducted research, five stages of the formation of the pharmaceutical supply system have been identified and outlined, which differ fundamentally across the range of criteria for analyzing effectiveness in building relationships between the state, civil society and the professional community. These stages were elaborated in accordance with the results of the analysis of the nature of relations between the authorities and society under the conditions of gradual transition from paternalistic to the elements of the patient-oriented model of medical and pharmaceutical services to the population: 1) 1990–1993; 2) 1994–2000; 3) 2001–2007; 4) 2008–2013; 5) from 2014 to the present. It has been proved that the stages of development of the domestic pharmaceutical supply system depend to a large extent on the nature of the influence of external environmental factors: changes of political elites in the country, global and internal financial crises, changes of priorities of the state development, breaking of social consciousness of the population against the background of political crisis, etc. It should be noted that the most important in terms of positive, first of all socio-economic, development characteristics is the fourth stage of formation (2008-2013) of the domestic system of pharmaceutical supply of the population. The last period (since 2014) is characterized by the existence of a crisis of relations between all subjects in the system of pharmaceutical provision of the population against the background of systemic transformations in the state, strengthening of the role of public professional associations and critical raising of public expectations from the state regarding the organization of providing affordable medical care to the population. and pharmaceutical assistance in the face of mass impoverishment.

Conclusion. The basic stages of the formation of the domestic pharmaceutical supply system are defined and their characteristics are envisaged, which allow to form in the future fundamentally new approaches to building rational, economically speaking, and simultaneously socially responsible relations between different subjects in the pharmaceutical market.


pharmaceutical supply system; health care; state regulation of pharmaceutical activity; pharmacy establishments; civil society

Full Text:



Susharyna, I. V., Nemchenko, A. S., Homenko, V. M. (2017). Identifying of the priority areas for improving of state and public regulation in pharmacy Pharmaceutical Review, 1, 38–44. doi:

Tkachenko, N. O., Hromovyk, B. P. (2019). Place and role modeling of social responsibility in professional activity of pharmaceutical specialists. Management, Economics and Quality Assurance in Pharmacy, 2 (58), 28–36. doi:

Kotvitska, A. A., Kubareva, I. V., Surikova, I. O. (2017). Study of the main stages of formation and development of social pharmacy in the world and in Ukraine. Pharmaceutical Review, 3, 70–76. doi:

Unhurian, L., Bielyaieva, O., Vyshnytska, I. et. al. (2018) Implementation of Standards of Good Pharmacy Practice in the World: A Review. Asian Journal of Pharmaceutics, 12 (1), 42–46.

Bratishko, Yu. S. (2017). Social responsibility of pharmaceutical business and it regulation to the international quality standards. Science and society: сollection of scientific articles, 106–111.

Eades, C. E., Ferguson, J. S., O’Carroll, R. E. (2011). Public health in community pharmacy: A systematic review of pharmacist and consumer views. BMC Public Health, 11 (1). doi:

Bush, P. W., Daniels, R. (2017). Health care systems and transitions of care: implication on interdisciplinary pharmacy services. North Carolina medical journal, 78 (3), 177–180. doi:

Blouin, R. A., Adams, M. L. (2017). The Role of the Pharmacist in Health Care: Expanding and Evolving. North Carolina Medical Journal, 78 (3), 165–167. doi:

Kar, S., Pradhan, H., Mohanta, G. (2010). Concept of essential medicines and rational use in public health. Indian Journal of Community Medicine, 35 (1), 10–13. doi:

Boryshchuk, V. O., Soloviov, O. S., Krasnianska, T. M. et. al. (2015). Doslidzhennia stanu orhanizatsii zabezpechennia naselennia likarskymy zasobamy v roky nezalezhnosti Ukrainy – stanovlennia farmatsevtychnoho rynku. Medychna informatyka ta inzheneriia, 3, 47–53.

Haque, M. (2017) Essential Medicine Utilization and Situation in Selected Ten Developing Countries: A Compendious Audit. Journal International Society of Preventive & Community Dentistry, 7 (4), 147–160.

Samborskyi, O., Slobodyanyuk, M., Panfilova, H. et. al. (2019). Аnalysis of changes in market characteristics of Essential Medicines within the frames of state program of increasing availability of medicines in Ukraine. Journal of Pharmaceutical Sciences and Research, 11 (5), 1679–1686.

WHO Model Lists of Essential Medicines. Available at:

Karanikolos, M., Mladovsky, P., Cylus, J., Thomson, S., Basu, S., Stuckler, D. et. al. (2013). Financial crisis, austerity, and health in Europe. The Lancet, 381 (9874), 1323–1331. doi:

Hemsley, S. (2018). Developing the role of the critical care pharmacist. The Pharmaceutical Journal. doi:

Etychnyi kodeks farmatsevtychnykh pratsivnykiv Ukrainy (2010). Available at:

Zakonodavstvo Ukrainy. Available at:

Dalton, K., Byrne, S. (2017). Role of the pharmacist in reducing healthcare costs: current insights. Integrated Pharmacy Research and Practice, 6, 37–46. doi:

Bratishko, Yu. S., Posylkina, O. V., Kubasova A. V. (2014). Modern state of personnel management in pharmaceutical enterprises. Institutionelle Grundlagen für die Funktionierung der Ökonomik unter den Bedingungen der Transformation: Sammelwerk der wissenschaftlichen Artikel, 1, 148–151.

Trygstad, T. (2017). Payment Reform Meets Pharmacy Practice and Education Transformation. North Carolina Medical Journal, 78 (3), 173–176. doi:

Kirsanov, D. (2019). Aptechnii rynok Ukrainy po itogam 2018 g.: Helicopter View. Ezhenedelnik Apteka, 2 (1173), 12–13.

Prykhodko, O., Kirsanov, D. (2014). Derehuliatsiia farmrynku zabezpechyt dostupnist likiv dlia ukraintsiv. Ezhenedelnyk Apteka, 34 (955). Available at:

Excessive Pricing in Pharmaceutical Markets – Note by Ukraine (2018). Available at:

Olasiuk, H. (2017). Competitive Forces on the Ukrainian Pharmaceutical Market: Evaluation Aspects Hanna Olasiuk, 2017. Journal of Applied Management and Investments, 6 (3), 186–196.

Ukrainian Pharmaceutical (2017). Available at:



  • There are currently no refbacks.

Copyright (c) 2019 Liliia Hala, Hanna Panfilova

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)